Previous issue | Volume 89 | ESPE2018 | Next issue

57th Annual ESPE

Athens, Greece
27 Sep 2018 - 29 Sep 2018

Card image cap
ESPE 2018 57th European Society for Paediatric Endocrinology Annual Meeting 27-29 September 2018 Athens, Greece

Free Communications

Multisystem Endocrine Disorders

Awareness and Participation in Rare Disease Registries Within the European Reference Network on Rare Endocrine Conditions (Endo-ERN)
aDevelopmental Endocrinology Research Group, School of Medicine, Dentistry and Nursing, University of Glasgow, Glasgow, UK; bOffice for Rare Conditions, Royal Hospital for Children and Queen Elizabeth University Hospital, Glasgow, UK; cDepartment of Paediatric Endocrinology, Ghent University, Ghent, Belgium; dDepartment of Endocrinology, William Harvey Research Institute, Barts and the London School of Medicine, Queen Mary University of London, London, UK; eDutch Adrenal Society, t’Harde, Netherlands; fNational Centre for Rare Diseases, Istituto Superiore di Sanità, Rome, Italy; gMed. Klinik und Poliklinik IV, Klinikum der Universität München, Munich, Germany; hDiabetes Center AUF DER BULT, Hannover, Germany; iUCL GOS Institute of Child Health, 30 Guilford Street, London, UK; jDepartments of Internal Medicine and Clinical Epidemiology, Leiden University Medical Centre, Leiden, Netherlands; kAPHP, Bicêtre Paris Sud, le Kremlin Bicêtre, Paris, France; lAPHP, Hôpitaux Universitaires Paris Est (AP-HP) Hôpital des Enfants Armand Trousseau, Paris, France; mPediatric Endocrinology, Karolinska University Hospital, S-17176, Stockholm, Sweden; nEndocrine Genetic Laboratory, Semmelweis University, Budapest, Hungary; oDivision of Endocrine and Metabolic Diseases, Istituto Auxologico Italiano, Milan, Italy; pDepartment of Clinical Sciences and Community Health, University of Milan, Milan, Italy; qMotol University Hospital, Prague, Czech Republic; rAcademic Centre for Thyroid Diseases, Erasmus Medical Centre, Rotterdam, Netherlands; sDivision of Paediatric Endocrinology and Diabetes, Department of Paediatrics and Adolescent Medicine, University of Lübeck, Lübeck, Germany; tDepartment of Medicine, Division of Endocrinology, Leiden University Medical Center, Leiden, Netherlands
hrp0089fc14.1
Regulation of Salt, Sugar and Sex Steroids in Humans by Genetic Variations in NADPH Cytochrome P450 Oxidoreductase (POR) Identified in 1000 Genome Samples
aUniversity Children’s Hospital Bern, Bern, Switzerland; bDepartment of Biomedical Research, University of Bern, Bern, Switzerland
hrp0089fc14.3
Pubertal Females Produce an Enhanced Interferon-Alpha, Anti-viral Response Compared to Males, Which is Associated with X Chromosome Number, and Not Sex Hormones
aArthritis Research UK Centre for Adolescent Rheumatology, UCL, UCLH and GOSH, London, UK; bDepartment of Paediatric and Adolescent Endocrinology, UCLH and UCL GOS Institute of Child Health, London, UK; cNIHR Biomedical Research Centre at GOSH, London, UK
hrp0089fc14.5
Sex Differences in Autoimmune Disease: Testosterone is Associated with a Decrease in Expression of Key Anti-viral Genes During Puberty, Which may Decrease the Risk of Autoimmunity in Males
aArthritis Research UK Centre for Adolescent Rheumatology, UCL, UCLH and GOSH, London, UK; bDepartment of Paediatric and Adolescent Endocrinology, UCLH and UCL GOS Institute of Child Health, London, UK; cNIHR Biomedical Research Centre at GOSH, London, UK
hrp0089fc14.6